Not Available Bangladesh Heart Journal 2020; 35(1) : 71-73

Background: Radiofrequency catheter ablation is a curative modality of treatment for paroxysmal supraventricular tachycardia. The aim of our study was to evaluate our experience of electrophysiology procedures and radiofrequency ablation in atrioventricular reciprocating tachycardia (AVRT). Methods: All patients undergoing cardiac electrophysiology and radiofrequency ablation procedures during the period from July, 2019 to July, 2021 at Department of Cardiology, Evercare Hospital, Dhaka were included in this study. The study analyzed 141 patients of among them 75(53.2%) patients were male and 66(46.8%) were female. Results: Patients who came with AVRT, 91 (65%) had concealed and 50 (35%) had manifested. The overall short term success rate was 99 %. There was no difference in the success rates between the younger and older patients. Complication rate is lower side of the spectrum, which is 1.4% (four patients). Conclusion: Radiofrequency ablation is a safe and successful treatment modality for patients with atrioventricular reciprocating tachycardia in this real - world study. Cardiovasc j 2022; 15(1): 20-25

One of the rare cardiac anomaly is Sinus of Valsalva aneurysm (SVA) that can rupture spontaneously into other cardiac chambers or the pericardial space.1 Here, we report a rare case of a right coronary sinus of Valsalva aneurysm with rupture into the Left ventricular outflow tract (LVOT). Cardiovasc j 2023; 15(2): 182-184

Atypical atrial flutter has become amenable to catheter ablation with remarkable improvement in the acute and long-term efficacy of this therapy for this macro reentrant atrial arrhythmia. Here it was described a case of atypical atrial flutter which arises from left atrium and demonstrates the importance of a systematic approach to mapping and ablating atypical atrial flutter to prevent a recurrence of symptomatic arrhythmia. We also highlighted importance of 3D mapping which is a key tool for analysis and successful ablation. Bangladesh Heart Journal 2022; 37(2): 139-142

Background: Primary percutaneous coronary intervention (pPCI) is the preferred and established mode of treatment in ST elevated myocardial infarction (STEMI). Exact data on procedural outcome in patient undergoing primary PCI in our population is not well documented. We have carried out this study to see the prognosis, in-hospital, and 12-month survival outcome of our patients. Methods: Patients were enrolled in the observational non-randomized prospective cohort between November 2017-Mar 2020, who were presented into our emergency department with acute onset of severe chest pain or angina with ECG evidenced acute ST elevated myocardial infarction. Total 182 patient (Female 14; Male 168) were enrolled in this study. Results: Out of 182 patients, anterior MI were 47.8% (n=87) and inferior MI 50.5% (n=92) and lateral MI 1.6% (n=3). Presentation to ER from the onset of chest pain for female :123 min vs. male: 112 min and average door-to-balloon time were for female: 53 min vs. male: 50 min. Hospital admission of STEMI were more after 5 pm to next morning 9 am. Death were more in anterior STEMI than inferior STEMI. At presentation 10.4% (n=19) patents were in cardiogenic shock with STEMI, 42.1%(n=8) patients with anterior MI, 57.9% (n=11) in inferior MI group. Total, 15 (8.2%) patients died; 93.3% (n=14) within one week of primary PCI due to shock and poor LV function and subsequent development of LVF with arrhythmia and 6.7% (n=1) patient died 6 months after pPCI due to other cause. Conclusion: In this prospective observational cohort study, we found that PCI is a good and effective treatment modality in treating STEMI patient with better myocardial salvage and avoidance of life-threatening complications. Our procedural success rate is 91.8% and patients are doing well with regular follow up at our OPD 12-months after primary PCI. Cardiovasc j 2022; 14(2): 111-120